New York Life Investment Management’s IQ Candriam US Mid Cap Equity ETF IQSM Stock Holding History
Bought
Maintained
Sold
Other funds holding IQSM
New York Life Investment Management's IQSM Position: Q2 2026 in Review
New York Life Investment Management increased its IQ Candriam US Mid Cap Equity ETF (IQSM) stake by 6.6% in Q2 2026, buying an estimated $19.5M and bringing the position to 8,329,582 shares worth $331M. The position accounts for 2.32% of the portfolio, ranked #7.
New York Life Investment Management first reported a position in IQSM in Q4 2022 and has held it in 15 quarters since. 2 funds tracked by Wall St. Rank hold IQSM as of Q2 2026.
- New York Life Investment Management held 8,329,582 shares of IQ Candriam US Mid Cap Equity ETF worth $331M as of Q2 2026.
- New York Life Investment Management bought 518,188 IQ Candriam US Mid Cap Equity ETF shares in Q2 2026, an estimated $19.5M.
- IQ Candriam US Mid Cap Equity ETF made up 2.32% of New York Life Investment Management's portfolio in Q2 2026, its #7 holding.
- New York Life Investment Management first reported a position in IQ Candriam US Mid Cap Equity ETF in Q4 2022 and has held it in 15 quarters since.
- 2 funds tracked by Wall St. Rank held IQ Candriam US Mid Cap Equity ETF as of Q2 2026.
Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.